104 results
6-K
EX-99.1
EVAX
Evaxion Biotech A/S
10 May 24
Evaxion Receives Nasdaq Notification
5:29pm
ongoing COVID-19 pandemic and the ongoing conflict in the region surrounding Ukraine and Russia and the Middle East; and other uncertainties
6-K
EX-99.1
EVAX
Evaxion Biotech A/S
17 Apr 24
Current report (foreign)
9:30am
ongoing COVID-19 pandemic and the ongoing conflict in the region surrounding Ukraine and Russia and the Middle East; and other uncertainties affecting our
6-K
EX-99.1
EVAX
Evaxion Biotech A/S
2 Apr 24
Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus Infection
8:00am
on our business from the worldwide ongoing COVID-19 pandemic and the ongoing conflict in the region surrounding Ukraine and Russia and the Middle East
6-K
EX-99.1
EVAX
Evaxion Biotech A/S
27 Mar 24
Evaxion Announces Business Update and Full Year 2023 Financial Results
8:30am
ongoing COVID-19 pandemic and the ongoing conflict in the region surrounding Ukraine and Russia and the Middle East; and other uncertainties affecting
6-K
EX-99.1
fm9h9ovu e4nsnhcj3m
19 Mar 24
Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ Platform
8:17am
6-K
EX-99.1
qrnlbw4i
29 Feb 24
Current report (foreign)
7:35am
6-K
EX-99.1
psjwpg1v7sdzmblnt
20 Feb 24
Evaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSD
7:32am
6-K
EX-99.1
mknym9eph
7 Feb 24
Current report (foreign)
8:30am
6-K
EX-99.1
movphcw rxvh
6 Feb 24
Evaxion Announces Closing of $15 Million Public Offering
8:30am
6-K
EX-99.1
pacpr t4v2
1 Feb 24
Evaxion Biotech Announces Pricing of $15 Million Public Offering
9:20am
F-1/A
k65qoo abb3r
30 Jan 24
Registration statement (foreign) (amended)
3:16pm
6-K
EX-99.1
stb684zq 4m
24 Jan 24
Evaxion to Develop Tailored Novel Cancer Vaccines Based upon a New Untapped Source of AI-Discovered Targets
2:11pm
6-K
EX-99.1
d1cfawexmk5l4p iy
22 Jan 24
Evaxion Announces Completion of ADS Ratio Change
4:45pm
F-1
p30auar m4k5ox0nj
12 Jan 24
Registration statement (foreign)
5:17pm
6-K
EX-99.1
b0ffz03
8 Jan 24
Evaxion Announces Plan to Implement ADS Ratio Change
8:30am
6-K
EX-99.2
akfhnk 2s6uyn
21 Dec 23
Current report (foreign)
4:45pm
6-K
EX-99.1
4qhi3ez ju
19 Dec 23
Evaxion Announces Business Update and Third Quarter 2023 Financial Results
4:45pm
6-K
EX-99.1
gdsgkwyueex vbd
19 Dec 23
Evaxion Biotech Announces Private Placement Financing
8:45am
6-K
EX-99.1
9x7ji5r9it
28 Nov 23
Evaxion to Unveil Potentially Groundbreaking AI-Immunology™ Precision Cancer Vaccine Concept
8:27am